Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
339 Views
Favorite
Facebook
Tweet
Print
Session: New Antimicrobials in the Pipeline Part 2
2011 - PC945 (OPELCONAZOLE) NEBULIZER SUSPENSION - a new inhaled antifungal in development for pulmonary aspergillosis
Saturday, October 14, 2023
8:00 AM – 8:12 AM
US ET
Location: 104 ABC
Speaker(s)
Lance Berman, MB.ChB (he/him/his)
Chief Medical Officer
Pulmocide Ltd
London, England, United Kingdom
Disclosure(s):
Lance Berman, MB.ChB
: Pulmocide Ltd.: Employee (Ongoing), Stocks/Bonds (Ongoing)
